About this trial
Targeted temporal interference stimulation (tTIS) of the nucleus accumbens (NAc) may modulate the abnormal electrophysiological activity in individuals with obsessive-compulsive disorder (OCD), thereby improving their obsessive-compulsive symptoms.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Were between 18 and 65 years old;
Were diagnosed with OCD by an experienced psychiatrist utilizing the Structured Clinical Interview for DSM-5 (SCID);
Were able to participate in the entire trial and face-to-face on-site assessment
Disqualifiers
Pregnant or breastfeeding;
Suffered from organic brain diseases or severe physical illness;
Had a history of substance or alcohol abuse;
Presence of comorbid psychiatric disorders (e.g., major depressive disorder) or a high risk of suicide;
Trial design
Parallel
Treatments tested in this trial
Transcranial Temporal Interference Stimulation
DeviceTranscranial temporal interference stimulation (tTIS) is a novel neurostimulation technique that utilizes two or more electric fields of specific frequencies to modulate the oscillations of neurons at the desired spatial location in the brain. The physics of tTIS offers the advantage of noninvasively regulating deep brain structures and minimally stimulating the overlying cortex outside the selected target.
Treatment groups
Trial outcomes
Primary outcomes
Obsessive-compulsive symptoms
Obsessive-compulsive symptom severity will be assessed using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). The Y-BOCS total score ranges from 0 to 40, with higher scores indicating greater symptom severity.
Secondary outcomes
Self-reported obsessive-compulsive symptoms
The reduction rate of the score of Obsessive-Compulsive Inventory-Revised (OCI-R), a self-rating scale of OCD symptoms severity, was employed as a secondary outcome.
Multimodal MRI measures
Multimodal MRI data will be acquired at baseline and after completion of the 5-day intervention using a 3.0-T MRI scanner. The imaging protocol includes T1-weighted and T2-weighted structural MRI, resting-state blood-oxygen-level-dependent (BOLD) functional MRI, and diffusion-weighted imaging (DWI).
Resting-state electroencephalography (EEG) measures
Resting-state EEG will be recorded at baseline and after completion of the 5-day intervention. Changes in EEG-derived neurophysiological measures between baseline and post-intervention will be assessed to characterize intervention-related alterations in brain activity.
Behavioral task performance
Behavioral task performance will be assessed at baseline and after the 5-day intervention using computerized cognitive tasks. Task-derived behavioral measures, such as instrumental learning tasks and probabilistic reversal learning tasks, will be analyzed to evaluate intervention-related changes in behavioral performance.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Beijing HuiLongGuan Hospital
Lead sponsor
Tsinghua University
Collaborator
The First People's Hospital of Hefei
Collaborator